Sign up to The Irish Times Archive (1859 - 2008)My Account »
Fri 04 Apr 2009Taking a clinical approach
THE FRIDAY INTERVIEW/Stefan Oschmann, Merck:IF ALL goes to plan, Stefan Oschmann will be kept busy over the next year or so bedding down the acquisition of Schering-Plough. With the $41.1 billion deal still in the balance, though, that’s a subject the Merck executive can’t discuss right now.
In the meantime, he is excited by the company’s significant expansion of its Irish business.
Choose a Subscription type - required
